Thursday, September 3, 2026

From X

Sangamo Bankruptcy (SGMOQ)

Sangamo Therapeutics’ Chapter 11 asset sales leave common equity tied to $100 million in PTC Fabry therapy approval milestones and a…

EVC Update

EVC reported a solid second quarter and outlook.

ZTS · long

Zoetis INC

Zoetis, the animal prescription-medicines company, is presented as a long investment despite concerns around its 2026 and 2027 outlook.

Publications we follow

Every publication on this site, hand-picked.

69 publications

X accounts we follow

Every account on this site, hand-picked.

55 accounts

Sectors

Ordered by how often our editor reaches for them.